Hudis CA: Trastuzumab--mechanism of action and use in clinical practice. N Engl J Med 357:39-51, 2007 37. Barok M, Isola J, Palyi-Krekk Z, et al: Trastuzumab causes antibody- dependent cellular cytotoxicity-mediated growth inhibition of submacroscopic JIMT-1 breast cancer xenografts despite intrinsic drug resistance. Mol Cancer Ther 6:2065-72, 2007 38.